Rossmore Private Capital - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 21 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rossmore Private Capital ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$186,000
-47.2%
40,6610.0%0.03%
-41.8%
Q1 2022$352,000
-52.6%
40,661
-21.8%
0.06%
-52.6%
Q4 2021$743,000
-28.1%
52,004
+10.6%
0.12%
-34.5%
Q3 2021$1,033,000
+411.4%
47,004
+212.1%
0.18%
+405.7%
Q2 2021$202,000
+32.0%
15,0610.0%0.04%
+20.7%
Q1 2021$153,000
+139.1%
15,0610.0%0.03%
+123.1%
Q4 2020$64,000
+64.1%
15,0610.0%0.01%
+44.4%
Q3 2020$39,000
-26.4%
15,0610.0%0.01%
-40.0%
Q2 2020$53,000
+15.2%
15,0610.0%0.02%
-6.2%
Q1 2020$46,000
-41.0%
15,0610.0%0.02%
-33.3%
Q4 2019$78,000
+62.5%
15,0610.0%0.02%
+50.0%
Q3 2019$48,000
-11.1%
15,0610.0%0.02%
-15.8%
Q2 2019$54,000
-1.8%
15,0610.0%0.02%
-5.0%
Q1 2019$55,000
+22.2%
15,0610.0%0.02%
+5.3%
Q4 2018$45,000
-38.4%
15,0610.0%0.02%
-34.5%
Q3 2018$73,000
-34.8%
15,0610.0%0.03%
-59.7%
Q2 2018$112,000
+14.3%
15,0610.0%0.07%
-27.3%
Q1 2018$98,000
-99.9%
15,0610.0%0.10%
-27.7%
Q4 2017$135,549,00015,0610.14%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders